Stories
Slash Boxes
Comments

SoylentNews is people

posted by martyb on Friday September 02 2016, @06:03PM   Printer-friendly
from the here's-hoping dept.

From a Science article:

[Newly] published results from a closely watched clinical trial are being hailed as a big win by some in the Alzheimer's treatment field. The trial data hint that an anti–β amyloid antibody drug called aducanumab warded off cognitive decline in people diagnosed with early Alzheimer's. But the trial, an early test of the antibody's safety, is still too small to prove conclusive, leading many others to caution against false hope.

[...] newly published results from a closely watched clinical trial are being hailed as a big win by some in the Alzheimer's treatment field. The trial data hint that an anti–β amyloid antibody drug called aducanumab warded off cognitive decline in people diagnosed with early Alzheimer's. But the trial, an early test of the antibody's safety, is still too small to prove conclusive, leading many others to caution against false hope.

[...] Overall, Alzheimer's researchers are urging caution about the new drug results—even those who are co-authors on the paper. The study was "grossly underpowered" to determine whether cognition was actually better in people who took aducanumab, or a statistical fluke

Phase III trials are currently in progress and should be completed by 2020.

http://www.nature.com/nature/journal/v537/n7618/full/nature19323.html
https://clinicaltrials.gov/ct2/show/NCT02477800
https://en.wikipedia.org/wiki/Aducanumab


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by bob_super on Friday September 02 2016, @06:54PM

    by bob_super (1357) on Friday September 02 2016, @06:54PM (#396746)

    Phase 1 trial successes are like Graphene miracles and Fusion breakthroughs: quite a few years and billions from being actually useful.

    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2